Cargando…

Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development

Detalles Bibliográficos
Autor principal:	Padmanabha Das, Krishna M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034765/ https://www.ncbi.nlm.nih.gov/pubmed/36968270 http://dx.doi.org/10.3389/fmolb.2023.1165208

Ejemplares similares

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

Editorial: Molecular Dynamics and Machine Learning in Drug Discovery
por: Decherchi, Sergio, et al.
Publicado: (2021)

Editorial: Integration of structural biology data in lead drug discovery and optimization
por: Roversi, Pietro, et al.
Publicado: (2023)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
por: Vitale, Rosa Maria, et al.
Publicado: (2023)

Editorial: RNAs at the crossroads between effectors and targets; discovery and development of new drugs
por: Chiappori, Federica, et al.
Publicado: (2023)

Editorial: Drug discovery from natural sources: Animal venoms, plants, bacteria and fungi
por: Kwok, Hang Fai
Publicado: (2022)

Editorial: Analytical devices based on immobilized macromolecules for structural and activity/affinity studies in drug discovery
por: Temporini, Caterina, et al.
Publicado: (2022)

Drug discovery by a basic research scientist
por: Eaton, William A.
Publicado: (2022)

Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020)

Recent Developments in Free Energy Calculations for Drug Discovery
por: King, Edward, et al.
Publicado: (2021)

Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
por: Laeremans, Toon, et al.
Publicado: (2022)

Hedgehog Autoprocessing: From Structural Mechanisms to Drug Discovery
por: Kandel, Nabin, et al.
Publicado: (2022)

Recent applications of computational methods to allosteric drug discovery
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2023)

Targeting the ubiquitin system by fragment-based drug discovery
por: Kennedy, Cassandra, et al.
Publicado: (2022)

Identification of Alternative Allosteric Sites in Glycolytic Enzymes for Potential Use as Species-Specific Drug Targets
por: Ayyildiz, Merve, et al.
Publicado: (2020)

High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
por: Vignoli, Alessia, et al.
Publicado: (2023)

Wrangling Shape-Shifting Morpheeins to Tackle Disease and Approach Drug Discovery
por: Jaffe, Eileen K.
Publicado: (2020)

Essential Dynamics Ensemble Docking for Structure-Based GPCR Drug Discovery
por: McKay, Kyle, et al.
Publicado: (2022)

Antibacterial and antibiofilm activity of Abroma augusta stabilized silver (Ag) nanoparticles against drug-resistant clinical pathogens
por: Kumar, Sachin, et al.
Publicado: (2023)

Editorial: Understanding Protein Dynamics, Binding and Allostery for Drug Design
por: Hu, Guang, et al.
Publicado: (2021)

Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022)

Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
por: Afzal, Samia, et al.
Publicado: (2022)

Editorial: Computational Approaches to Study the Impact of Mutations on Disease and Drug Resistance
por: Ben-Tal, Nir, et al.
Publicado: (2021)

Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development
por: Cardoso, Fernanda C., et al.
Publicado: (2022)

Editorial: Drug Delivery System Based on Nanoparticles for Inflammation and Cancer Therapy
por: Zhang, Mingxin, et al.
Publicado: (2022)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Editorial: Applications of metabolomics to the discovery of biomolecules from natural products
por: Choi, Young Hae, et al.
Publicado: (2023)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Structural modeling of antibody variable regions using deep learning—progress and perspectives on drug discovery
por: Jaszczyszyn, Igor, et al.
Publicado: (2023)

X-ray crystallography and sickle cell disease drug discovery—a tribute to Donald Abraham
por: Donkor, Akua K., et al.
Publicado: (2023)

Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)

Editorial: Venom peptides: A rich combinatorial library for drug development, volume II
por: Servent, Denis, et al.
Publicado: (2023)

Editorial: New Strategies for the Diagnosis and Treatment of Multi-Drug Resistant Bacteria or Fungi in Wounds
por: Chin, Kok-Yong
Publicado: (2023)

Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022)

Editorial: Advances and challenges in untargeted metabolomics
por: Wawrzyniak, Renata, et al.
Publicado: (2023)

Drug Weaponry to Fight Against SARS-CoV-2
por: Cabezón, Elena, et al.
Publicado: (2020)

In silico identification of modulators of J domain protein-Hsp70 interactions in Plasmodium falciparum: a drug repurposing strategy against malaria
por: Singh, Harpreet, et al.
Publicado: (2023)

Editorial: Going the Distance: Enabling 3D Cell Culture Systems for Biomedical Research and Drug Treatment
por: Teng, Yong, et al.
Publicado: (2021)

Editorial: Technical Advances in Cryo-Electron Microscopy
por: Rivera-Calzada, Angel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gul3pgliojq7ug2co74v8dfnu1